Ann: Material Revenues Confirmed from Non-Pharma Business Units, page-71

Problem is there have to be people selling shares at lower prices for other people to buy them. Lot of very small trades under $500 and quite a few under $100.

Not sure of how many Australian listed MM companies have the amount of revenue relative to their capital value that MXC has - nor the clear prospects either. Maybe someone know how to find that information.

I will gladly go on record to say that MXC is grossly undervalued. Something is always a bit fishy when a company has a huge announcement (and it really is) and the SP does nothing.The real biggie will be the September quarterly report - always posted here that we need to see the next two to make up our minds - the lasts announcement reinforces that view now.